Clinical Trial Update: The FLUYDO NC Post Market Clinical Follow-up Study

View source ↗

Summary

The FLUYDO NC post-market clinical follow-up study sponsored by Alvimedica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Vascular Diseases

Snippet

Sponsor: Alvimedica | Conditions: Coronary Artery Disease, Coronary Disease | Status: COMPLETED